Last updated on February 2018

Oral Challenge in the Pediatric ED

Brief description of study

Our primary objective is to demonstrate the feasibility of utilizing a novel penicillin allergy questionnaire in the PED to identify a low-risk group of patients who will complete an oral challenge in the PED to test for an IgE-mediated allergic reaction. This project will begin as a single site feasibility study, however including up to 2 other collaborative sites for enrollment has been favorably discussed. We do not anticipate this to be a single IRB scenario and will submit a timely comprehensive amendment if plans become concrete and the initial data here proves reliable.

Our secondary objective is to examine whether health care outcomes and prescription-related costs are comparable between children who are de-labeled as penicillin allergic after an oral challenge compared to a standard of care group who are not challenged in the PED.

Clinical Study Identifier: NCT03404804

Find a site near you

Start Over

David Vyles

Milwaukee, WI United States
  Connect »